gp100 (476-485)

gp100 (476-485) is a synthetic peptide fragment corresponding to amino acids 476 through 485 of the human glycoprotein 100 (gp100), a melanocyte differentiation antigen highly expressed in melanoma cells. As a well-characterized epitope, this decapeptide plays a significant role in immunological research, particularly in studies involving antigen processing and T cell recognition. Its sequence is recognized by specific cytotoxic T lymphocytes (CTLs), making it a valuable reagent for dissecting immune responses to melanoma-associated antigens. The biochemical properties of gp100 (476-485) lend themselves to a range of experimental applications in cellular immunology, peptide-MHC interaction studies, and the development of immunological assays.

Epitope mapping: Researchers frequently employ this peptide for detailed epitope mapping studies, aiming to elucidate the precise regions of gp100 recognized by T cell receptors. By using gp100 (476-485) in in vitro assays, investigators can identify T cell clones specific for this epitope and characterize the fine specificity of immune recognition. Such mapping is essential for understanding antigenic determinants in tumor immunology and for guiding the design of peptide-based immunological tools.

Immunogenicity assessment: The peptide serves as a robust model antigen for evaluating T cell immunogenicity in both basic and translational research settings. Its defined sequence allows for the quantification of CTL responses in peripheral blood mononuclear cells (PBMCs) or other relevant cell populations. By stimulating T cells with gp100 (476-485), scientists can assess the magnitude and quality of antigen-specific immune responses, providing critical data for immunomonitoring and vaccine research.

Peptide-MHC binding studies: The affinity of gp100 (476-485) for specific major histocompatibility complex (MHC) molecules, particularly HLA-A2, makes it a valuable tool for analyzing peptide-MHC interactions. Researchers utilize this peptide to investigate the structural and functional parameters governing MHC class I peptide presentation, contributing to a deeper understanding of antigen presentation mechanisms. Such studies enable the optimization of peptide design for improved MHC binding and immune recognition.

Assay development: The defined immunological properties of this peptide facilitate the development of sensitive and specific assays for T cell detection, such as enzyme-linked immunospot (ELISpot), intracellular cytokine staining, and tetramer-based flow cytometry. Incorporating gp100 (476-485) as a target antigen in these assays allows for the reliable detection and quantification of antigen-specific T cell populations, supporting both basic research and preclinical development efforts.

Peptide-based vaccine research: In the context of experimental vaccine development, gp100 (476-485) is widely used as a prototype antigen to evaluate peptide-based immunization strategies. Its well-characterized immunogenicity and relevance to melanoma-associated antigens make it an ideal candidate for testing adjuvant formulations, delivery systems, and immunomodulatory approaches. These studies provide valuable insights into the principles of peptide vaccine design and the generation of effective cellular immune responses against tumor antigens.

1. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs